Vascular pathologies in chronic kidney disease: pathophysiological mechanisms and novel therapeutic approaches

• Published in: Journal of molecular medicine (Berlin, Germany) Vol. 99; no. 3; pp. 335 - 348
• Main Authors: Düsing, Philip, Zietzer, Andreas, Goody, Philip Roger, Hosen, Mohammed Rabiul, Kurts, Christian, Nickenig, Georg, Jansen, Felix
• Format: Journal Article
• Language: English
• Published: Berlin/Heidelberg Springer Berlin Heidelberg 01-03-2021; Springer Nature B.V
• Subjects: Arteriosclerosis; Atherosclerosis; Biomedical and Life Sciences; Biomedicine; Blood vessels; Calcification (ectopic); Cardiovascular diseases; Cell signaling; Extracellular matrix; Extracellular vesicles; Human Genetics; Hyperphosphatemia; Internal Medicine; Kidney diseases; Mineralization; miRNA; Molecular Medicine; Oxidative stress; Phenotypes; Review; Risk factors; Smooth muscle; Therapeutic targets; Vitamin K; Vascular calcification; Chronic kidney disease; Coronary artery disease; Atherosclerosis
• ISSN: 0946-2716; 1432-1440
• DOI: 10.1007/s00109-021-02037-7

Cardiovascular disease (CVD) is a major cause of death in patients with chronic kidney disease (CKD). Both conditions are rising in incidence as well as prevalence, creating poor outcomes for patients and high healthcare costs. Recent data suggests CKD to be an independent risk factor for CVD. Accumulation of uremic toxins, chronic inflammation, and oxidative stress have been identified to act as CKD-specific alterations that increase cardiovascular risk. The association between CKD and cardiovascular mortality is markedly influenced through vascular alterations, in particular atherosclerosis and vascular calcification (VC). While numerous risk factors promote atherosclerosis by inducing endothelial dysfunction and its progress to vascular structural damage, CKD affects the medial layer of blood vessels primarily through VC. Ongoing research has identified VC to be a multifactorial, cell-mediated process in which numerous abnormalities like mineral dysregulation and especially hyperphosphatemia induce a phenotype switch of vascular smooth muscle cells to osteoblast-like cells. A combination of pro-calcifying stimuli and an impairment of inhibiting mechanisms like fetuin A and vitamin K-dependent proteins like matrix Gla protein and Gla-rich protein leads to mineralization of the extracellular matrix. In view of recent studies, intercellular communication pathways via extracellular vesicles and microRNAs represent key mechanisms in VC and thereby a promising field to a deeper understanding of the involved pathomechanisms. In this review, we provide an overview about pathophysiological mechanisms connecting CKD and CVD. Special emphasis is laid on vascular alterations and more recently discovered molecular pathways which present possible new therapeutic targets.